{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:52:05Z","timestamp":1788382325737,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Development of Innovative Test in the Area of Genetics Based on the NGS Technology","award":["UDA-POIG.01.04.00-30-027\/12-00"],"award-info":[{"award-number":["UDA-POIG.01.04.00-30-027\/12-00"]}]},{"name":"European Union under the European Regional Development Fund - Activity 1.4"},{"name":"Innovative Economy Operational Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HLA"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mixed connective tissue disease (<jats:styled-content style=\"fixed-case\">MCTD<\/jats:styled-content>) is a systemic autoimmune disease, originally defined as a connective tissue inflammatory syndrome with overlapping features of systemic lupus erythematosus (<jats:styled-content style=\"fixed-case\">SLE<\/jats:styled-content>), rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>), polymyositis\/dermatomyositis (<jats:styled-content style=\"fixed-case\">PM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content>) and systemic sclerosis (<jats:styled-content style=\"fixed-case\">SSc<\/jats:styled-content>), characterized by the presence of antibodies against components of the <jats:styled-content style=\"fixed-case\">U1<\/jats:styled-content> small nuclear ribonucleoprotein (<jats:styled-content style=\"fixed-case\">U1snRNP<\/jats:styled-content>). The aim of the study was to assess the frequency of (high\u2010resolution\u2010typed) <jats:styled-content style=\"fixed-case\">DRB1<\/jats:styled-content> alleles in a cohort of Polish patients with <jats:styled-content style=\"fixed-case\">MCTD<\/jats:styled-content> (<jats:italic>n<\/jats:italic> = 103). Identification of the variants potentially associated with risk and protection was carried out by comparison with the <jats:styled-content style=\"fixed-case\">DKMS<\/jats:styled-content> Polish Bone Marrow Donor Registry (41306 alleles). <jats:italic><jats:styled-content style=\"fixed-case\">DRB1<\/jats:styled-content>*15:01<\/jats:italic> (odds ratio (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>): 6.06; 95% confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) 4.55\u20138.06), <jats:italic><jats:styled-content style=\"fixed-case\">DRB1<\/jats:styled-content>*04<\/jats:italic> (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 3.69; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 2.69\u20135.01) and <jats:italic>*09:01<\/jats:italic> (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 8.12; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 2.15\u201321.75) were identified as risk alleles for <jats:styled-content style=\"fixed-case\">MCTD<\/jats:styled-content>, while <jats:italic><jats:styled-content style=\"fixed-case\">HLA\u2010DRB1<\/jats:styled-content>*07:01<\/jats:italic> allele was found to be protective (<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>: 0.50; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.28\u20130.83). The carrier frequency of the <jats:italic><jats:styled-content style=\"fixed-case\">DRB1<\/jats:styled-content>*01<\/jats:italic> was higher in <jats:styled-content style=\"fixed-case\">MCTD<\/jats:styled-content> patients compared with controls, although the differences were not statistically significant. Our results confirm the modulating influence of <jats:styled-content style=\"fixed-case\">HLA\u2010DRB1<\/jats:styled-content> genotypes on development of connective tissue diseases such as <jats:styled-content style=\"fixed-case\">MCTD<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/tan.12698","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T10:42:53Z","timestamp":1447065773000},"page":"13-18","source":"Crossref","is-referenced-by-count":23,"title":["Association of HLA\u2010DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients"],"prefix":"10.1111","volume":"87","author":[{"given":"A.","family":"Paradowska\u2010Gorycka","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stypi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Olesi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Felis\u2010Giemza","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ma\u0144czak","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Promotion National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Czuszynska","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Connective Tissue Disease and Geriatrics Medical University of Gdansk  Gdansk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zdrojewski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Connective Tissue Disease and Geriatrics Medical University of Gdansk  Gdansk Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wojciechowicz","sequence":"additional","affiliation":[{"name":"DNA Research Center  Poznan Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jurkowska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology National Institute of Geriatrics, Rheumatology and Rehabilitation  Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2283rr"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780180601"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0519-6"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90064-2"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.01.009"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.03.003"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9887-0"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-012-8270-1"},{"key":"e_1_2_7_10_1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/archderm.1976.01630350011003","article-title":"Mixed connective tissue disease","volume":"112","author":"Minkin W","year":"1976","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_11_1","first-page":"706","article-title":"The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity","volume":"4","author":"Malmegrim KC","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.10.002"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2005.04.009"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00776-0"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu310"},{"key":"e_1_2_7_17_1","first-page":"2136","article-title":"Serum cytokine levels and type 1 and type 2 intracellular t cell cytokine profiles in mixed connective tissue disease","volume":"29","author":"Bodolay E","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb03127.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00930.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.6.3429"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1490"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.32.22321"},{"key":"e_1_2_7_23_1","volume-title":"Mixed Connective Tissue Disease and Antinuclear Antibodies","author":"Kasukawa R"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8444"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0001-2815.2004.00214.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2007.01.014"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2011.03.010"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00991.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.03.461"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1993.tb01972.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00776-0"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12027"},{"key":"e_1_2_7_33_1","first-page":"91","article-title":"Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population","volume":"17","author":"Weckmann AL","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L"}],"container-title":["HLA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftan.12698","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tan.12698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:53:34Z","timestamp":1696172014000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tan.12698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1111\/tan.12698"],"URL":"https:\/\/doi.org\/10.1111\/tan.12698","archive":["Portico"],"relation":{},"ISSN":["2059-2302","2059-2310"],"issn-type":[{"value":"2059-2302","type":"print"},{"value":"2059-2310","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}